Cargando…
Corrigendum: Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance
Autores principales: | Lin, Xixi, Jia, Yongliang, Dong, Xinwei, Shen, Jian, Jin, Yachao, Li, Yanyou, Wang, Fang, Anenberg, Eitan, Zhou, Jiancang, Zhu, Jianping, Chen, Xiaoping, Xie, Qiangmin, Xie, Yicheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097790/ https://www.ncbi.nlm.nih.gov/pubmed/35571124 http://dx.doi.org/10.3389/fphar.2022.890886 |
Ejemplares similares
-
Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance
por: Lin, Xixi, et al.
Publicado: (2019) -
Pharmacokinetics and Tissue Distribution of Nasal Spray of a Novel Muscarinic Receptor Blocker, 101BHG-D01, in Dogs and Rats
por: Wei, Hao, et al.
Publicado: (2022) -
NEFA‐induced ROS impaired insulin signalling through the JNK and p38MAPK pathways in non‐alcoholic steatohepatitis
por: Gao, Wenwen, et al.
Publicado: (2018) -
Caspase‐3‐mediated GSDME induced Pyroptosis in breast cancer cells through the ROS/JNK signalling pathway
por: Zhang, Ziwen, et al.
Publicado: (2021) -
Canagliflozin Delays Aging of HUVECs Induced by Palmitic Acid via the ROS/p38/JNK Pathway
por: Hao, Wenhui, et al.
Publicado: (2023)